Mechanisms and dynamics of T cell-mediated cytotoxicity in vivo
S Halle, O Halle, R Förster - Trends in immunology, 2017 - cell.com
Cytotoxic T lymphocytes (CTLs) are critical in the elimination of infected or malignant cells
and are emerging as a major therapeutic target. How CTLs recognize and kill harmful cells …
and are emerging as a major therapeutic target. How CTLs recognize and kill harmful cells …
In vivo killing capacity of cytotoxic T cells is limited and involves dynamic interactions and T cell cooperativity
S Halle, KA Keyser, FR Stahl, A Busche, A Marquardt… - Immunity, 2016 - cell.com
According to in vitro assays, T cells are thought to kill rapidly and efficiently, but the efficacy
and dynamics of cytotoxic T lymphocyte (CTL)-mediated killing of virus-infected cells in vivo …
and dynamics of cytotoxic T lymphocyte (CTL)-mediated killing of virus-infected cells in vivo …
Facts and hopes in immunotherapy strategies targeting antigens derived from KRAS mutations
GP Linette, AS Bear, BM Carreno - Clinical Cancer Research, 2024 - AACR
In this commentary, we advance the notion that mutant KRAS (mKRAS) is an ideal tumor
neoantigen that is amenable for targeting by the adaptive immune system. Recent progress …
neoantigen that is amenable for targeting by the adaptive immune system. Recent progress …
Landscape of exhausted virus-specific CD8 T cells in chronic LCMV infection
I Sandu, D Cerletti, N Oetiker, M Borsa, F Wagen… - Cell Reports, 2020 - cell.com
A hallmark of chronic infections is the presence of exhausted CD8 T cells, characterized by a
distinct transcriptional program compared with functional effector or memory cells, co …
distinct transcriptional program compared with functional effector or memory cells, co …
Exhausted CD8+ T cells exhibit low and strongly inhibited TCR signaling during chronic LCMV infection
Chronic viral infections are often associated with impaired CD8+ T cell function, referred to
as exhaustion. Although the molecular and cellular circuits involved in CD8+ T cell …
as exhaustion. Although the molecular and cellular circuits involved in CD8+ T cell …
Sublethal whole-body irradiation induces permanent loss and dysfunction in pathogen-specific circulating memory CD8 T cell populations
M Heidarian, IJ Jensen, SK Kannan… - Proceedings of the …, 2023 - National Acad Sciences
The increasing use of nuclear energy sources inevitably raises the risk of accidental or
deliberate radiation exposure and associated immune dysfunction. However, the extent to …
deliberate radiation exposure and associated immune dysfunction. However, the extent to …
T‐cell heterogeneity, progenitor–progeny relationships, and function during latent and chronic viral infections
Upon resolution of an acute viral infection, during latent‐reactivating infection and during
chronic active infections virus‐specific T‐cells differentiate into distinct subsets that differ in …
chronic active infections virus‐specific T‐cells differentiate into distinct subsets that differ in …
Understanding experimental LCMV infection of mice: the role of mathematical models
G Bocharov, J Argilaguet… - Journal of immunology …, 2015 - Wiley Online Library
Virus infections represent complex biological systems governed by multiple‐level regulatory
processes of virus replication and host immune responses. Understanding of the infection …
processes of virus replication and host immune responses. Understanding of the infection …
Immune-surveillance through exhausted effector T-cells
D Zehn, DT Utzschneider, R Thimme - Current opinion in virology, 2016 - Elsevier
Highlights•The phenomenon of T-cell exhaustion limits immune responses to persisting
infections.•Nonetheless, these T-cells retain a certain level of function.•We review evidence …
infections.•Nonetheless, these T-cells retain a certain level of function.•We review evidence …
Loss of p14 diminishes immunogenicity in melanoma via non‐canonical Wnt signaling by reducing the peptide surface density
J Wohlfarth, C Kosnopfel, D Faber… - Molecular …, 2024 - Wiley Online Library
Immunotherapy has achieved tremendous success in melanoma. However, only around
50% of advanced melanoma patients benefit from immunotherapy. Cyclin‐dependent …
50% of advanced melanoma patients benefit from immunotherapy. Cyclin‐dependent …